HSV-2 is one of the most common sexually transmitted infections in the world. Globally, around 520 million people aged 15 to 49 are living with it, and in the United States, roughly 12% of people in that age range test positive. Despite how widespread it is, more than 80% of people with HSV-2 have never been diagnosed, either because they have no symptoms or because their symptoms are mild enough to go unnoticed.
Global and U.S. Prevalence
The World Health Organization estimates that more than 1 in 5 adults worldwide has a genital herpes infection when both HSV-1 and HSV-2 genital cases are counted together. HSV-2 alone accounts for 520 million of those cases as of 2020.
In the United States, national survey data from 2015 to 2016 put the HSV-2 prevalence at 12.1% among people aged 14 to 49. That translates to roughly one in eight people in that age range. The rate is higher among women than men, and it climbs with age since the virus stays in the body for life and cumulative exposure increases over the years.
Rates Vary Significantly by Demographics
HSV-2 does not affect all groups equally. U.S. data from the same national surveys show sharp differences by race and ethnicity. Among non-Hispanic Black Americans aged 14 to 49, the prevalence was 34.6%, compared to 8.1% among non-Hispanic white Americans and 9.4% among Mexican Americans. These disparities reflect differences in sexual network patterns, access to healthcare, and other social determinants rather than any biological susceptibility.
Women are infected at higher rates than men across virtually every demographic group. This is partly because male-to-female transmission is more efficient than the reverse. In studies of couples where one partner has HSV-2 and the other does not, women acquired the infection at roughly 1.6 times the rate of men.
Rates Have Been Declining
HSV-2 prevalence in the U.S. has dropped meaningfully over the past two decades. In 1999 to 2000, 18% of people aged 14 to 49 tested positive. By 2015 to 2016, that figure had fallen to 12.1%, a decline of nearly 6 percentage points. The downward trend held across all racial and ethnic groups measured. Non-Hispanic Black prevalence dropped from 41.5% to 34.6%, non-Hispanic white prevalence from 14.1% to 8.1%, and Mexican American prevalence from 12.8% to 9.4%.
The reasons for the decline aren’t fully pinned down, but likely include changes in sexual behavior, increased condom use, and greater awareness of sexually transmitted infections over this period.
Most People Don’t Know They Have It
This is the single most important thing to understand about HSV-2 prevalence: the vast majority of infected people are unaware. More than 80% of HSV-2 infections are either completely asymptomatic, produce symptoms too mild to notice, or get misdiagnosed as something else because they don’t look like the “classic” genital ulcers most people picture.
Many people experience their first recognizable outbreak years after they were actually infected, if they ever have one at all. This means that someone who has never had visible sores can still carry and transmit the virus. It also means that standard STI panels, which typically do not include herpes blood tests, leave most carriers undiagnosed.
How HSV-2 Spreads Between Partners
HSV-2 spreads through skin-to-skin contact during sexual activity, and it can be transmitted even when no sores are visible. This is because the virus periodically reactivates and reaches the skin surface without causing noticeable symptoms, a process called asymptomatic shedding.
In men with HSV-2 who have a history of genital herpes, the virus was detectable on the skin about 5.3% of days overall, with subclinical (no visible symptoms) shedding occurring on about 2% of days. Even men who had never been diagnosed with genital herpes but tested positive for HSV-2 antibodies shed the virus on roughly 3.6% of days. Women tend to shed at somewhat higher rates. These percentages may sound small, but over the course of months or years of a sexual relationship, they add up.
Transmission risk between long-term couples varies depending on direction. In studies tracking couples where one partner was HSV-2 positive and the other was not, women acquired the infection at higher rates than men. Daily antiviral medication and consistent condom use each reduce transmission risk by roughly half, and combining both offers even greater protection.
How HSV-2 Testing Works
If you want to know your HSV-2 status, the most common approach is a type-specific blood test that looks for antibodies to the virus. The standard version of this test has a sensitivity of about 97%, meaning it catches almost all true infections, and a specificity of 89 to 93%, meaning it occasionally produces false positives. Using a higher cutoff value on the test improves specificity to 96 to 98% while still catching about 90% of true infections.
Because of the false positive issue, a low-positive result (index values between 1.1 and 3.5) is sometimes worth confirming with a more specialized test. If you have visible sores, a swab test can identify the virus directly and is more straightforward to interpret.
Connection to HIV Risk
HSV-2 has a well-documented relationship with HIV. Having an HSV-2 infection at least triples the risk of acquiring HIV if exposed. This is because the inflammation and microscopic breaks in skin caused by herpes, even during asymptomatic shedding, create entry points for HIV. In regions with high rates of both infections, HSV-2 is considered a significant driver of HIV transmission at the population level.